THOR News and Press, Synthorx Inc. From 12/12/19

NEW YORK, NY / ACCESSWIRE / December 12, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: William Lyon Homes ( WLH ) related to its...

NEW YORK, NY / ACCESSWIRE / December 11, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Instructure, Inc (NYSE: INST ) related to...

On Dec. 9, pharmaceutical giant Sanofi (NASDAQ: SNY)  said it's buying immuno-oncology company Synthorx (NASDAQ: THOR) for $2.5 billion to boost its cancer and autoimmune program.  Considering the performance of Sanofi's businesses, the pipeline Synthorx brings to the ...

Major benchmarks drifted lower Monday as uncertainty over a trade deal continued to weigh on the market. The  Dow Jones Industrial Average (DJINDICES: ^DJI)  and the  S&P 500 (SNPINDEX: ^GSPC)  closed near session lows. Data source: Yahoo! Finance. As for individual...

The Internet Pounces on their Marketing and Peloton Stock Suffers Last week the Twitterverse stormed and condemned Peloton ( PTON ). It has been the target of satirical YouTube videos; Aviation Gin even created a YouTube ad spoofing Peloton and drafting off of PTON’s misery. Has PTO...

Gainers: Synthorx (NASDAQ: THOR )  +170% . More news on: Synthorx, Inc., ArQule, Inc., Forty Seven, Inc., Stocks on the move, Read more ...

NEW YORK, Dec. 09, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Synthorx, Inc. (NASDAQ: THOR) to Sanofi for $68.00 per share is fair to Synthorx shareholders. On behalf of Synthorx shareholders, Halper Sadeh LLP may seek ...

Shares of the clinical-stage biotech Synthorx (NASDAQ: THOR) jumped by an eye-popping 169% right out of the gate Monday morning. What's behind this enormous spike? Synthorx's stock is on fire today in response to an all-cash buyout agreement with French pharma giant Sanofi (NASDAQ: SNY...

DENVER, Colo., December 9, 2019- (24/7MarketNews via COMTEX) Venture Market News for December 9, 2019. Market Trend As the US-China trade talks may continue to try to take up all the air in the room, biotech M&A activity is quietly picking up, with two high premium acquisitions in the spce...

Synthorx (NASDAQ: THOR ) +169%  on being acquired by Sanofi. More news on: Synthorx, Inc., XBiotech Inc., ArQule, Inc., Stocks on the move, Read more ...